LMAT
$47.74
Lemaitre Vascular
($.88)
(1.81%)
LMAT
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.32
Revenue:  $36.13 Mil
Thursday
Jul 29
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, April 29, 2021

What do you expect when LMAT reports earnings?
Beat
Meet
Miss

Where is LMAT's stock price going from here?
Up
Flat
Down
Stock chart of LMAT
Analysts
Summary of analysts' recommendations for LMAT
Score
Grade
Pivots
Resistance
$50.60
$49.81
$48.78

$47.99

Support
$46.96
$46.17
$45.14
Tweet
Growth
Description
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Peers
StrykerBoston ScientificBaxter InternationalBecton, DickinsonAbbottWaters3MCardiovascular SystemsResMedTeleflex